title: DHPG at CMV viremia after allogeneic bone marrow transplantation. Result over a four year period (1986-1990).
authors.affiliation: Dept. of Haematology, C.H.U. Nantes, France.
authors.forename: N
authors.initials: N
authors.lastname: Milpied
authors.forename: J L
authors.initials: JL
authors.lastname: Harousseau
authors.forename: P
authors.initials: P
authors.lastname: Moreau
authors.forename: F
authors.initials: F
authors.lastname: Lacroix
authors.forename: J F
authors.initials: JF
authors.lastname: Ramee
authors.forename: S
authors.initials: S
authors.lastname: Billaudel
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D015331:Cohort Studies; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology / Q000635:transmission; D004341:Drug Evaluation; D004797:Enzyme-Linked Immunosorbent Assay; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010865:Pilot Projects; D011446:Prospective Studies; D014766:Viremia / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000914:Antibodies, Viral; D015774:Ganciclovir